About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Study of Genetics in Childhood Obesity | Clinical Trials | Clareo Health

Back to clinical trial search

Not Yet RecruitingNCT07487584

Study of Genetics in Childhood Obesity

Childhood obesity is a major and growing health concern in the UK. Around 1 in 7 children aged 2-15 are living with obesity, which can lead to serious health problems and early death later in life. So...

Lead sponsor: Georgina Yan•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Georgina Yan

Collaborators

Norfolk and Norwich University Hospitals NHS Foundation Trust
Oxford University Hospitals NHS Trust
Manchester University NHS Foundation Trust
Birmingham Women's and Children's NHS Foundation Trust
Bristol Royal Hospital for Children
Frimley Park Hospital NHS Trust
Dartford and Gravesham NHS Foundation Trust
Portsmouth Hospitals NHS Trust
Nottingham University Hospitals NHS Trust

Age

2 - 18 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Aged 2-18 years old
•Early onset of obesity (before 5 years old)
•Obesity (BMI SDS ≥3/ ≥99.6th percentile)
•Attended a Complications of Excess Weight (CEW) clinic appointment between 2021 and 2025 (inclusive) and had a genetic investigation (R149 and/or CGH) array

Exclusion Criteria

•Onset of obesity after 5 years of age
•History of chemotherapy, radiotherapy, antipsychotics and steroid use (possible iatrogenic causes of obesity)
•Known diagnosis of craniopharyngioma or hypothalamic tumour

Related studies

Five PLus Year EffIcacy of Endoscopic Sleeve Gastroplasty (ESG) for Sustained WeigHT Loss

NCT06894498 · Obesity and Obesity-related Medical Conditions, Weight Loss

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes

NCT05124808 · Gestational Diabetes, Pregnancy, High Risk, and more

RECRUITINGPhase 3

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

NCT06937086 · Ulcerative Colitis, Obesity or Overweight

RECRUITINGPhase 3

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

NCT07595549 · Obesity, Overweight and/or Obesity, and more

RECRUITINGPhase 3

Efficacy and Safety of KAI-9531 in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

NCT07284875 · Obesity, Overweight

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 25, 2026Terms

Trial snapshot

StatusNOT_YET_RECRUITING

Phase—

Enrollment500

Start dateJun 2026

Last updatedMar 25, 2026

Condition

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 25, 2026Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions